Frank Nestle
Partner and Chief Executive Officer @ Deerfield Management
Cambridge, United States
Frank Nestle is a seed investor at Deerfield Management in Cambridge focused on Therapeutics and Biotechnology. Frank Nestle is the current Partner and Chief Executive Officer of Deerfield Management. He previously worked at Kiadis Pharma as a Chairman of the Board. Frank Nestle attended The Julius Maximilians University of Würzburg.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Frank Nestle invests in
Stages Frank Nestle invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Boulevard Bio is a biotechnology company founded by Deerfield Management that develops novel therapies for cardiometabolic and specialty disorders. | $65M / Seed / Aug 12, 2026 |
About Deerfield Management
Deerfield Management focuses on advancing healthcare through investment, research, and philanthropic efforts. The firm manages investment strategies that span across public and private markets, targeting companies involved in biotechnology, pharmaceuticals, diagnostics, healthcare services, and medical technology. In addition to capital deployment,Deerfield supports early-stage innovation through strategic partnerships and dedicated facilities that foster scientific research and drug discovery. The organization also operates a philanthropic foundation that funds education, healthcare access, and initiatives aimed at improving health outcomes.
Deerfield Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Mussaad Al-Razouki
Operating Partner
|
|||
Cameron Wheeler
Partner
|
|||
|
David Greenwald
Vice President, Business Development
|
|||
|
Frank Nestle
Partner and Chief Executive Officer
|
|||
Timothy Leahy
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Frank Nestle invest in?
Frank Nestle invests primarily in Therapeutics and Biotechnology startups, most often at Seed stage. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Frank Nestle?
Public channels for Frank Nestle include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Frank Nestle last invest?
The most recent investment recorded for Frank Nestle closed in Aug 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
